Doctor profile · Federal record
Dr. Ross Kerns, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Knoxville, TN
- NPI 1023018728
- Accepts Medicare
- MIPS 74.4 / 100 · 2023
- 42 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9957 Sherrill Blvd
Knoxville, TN 379323366
(865) 639-2255
fax (865) 691-7888 - Mailing address
-
6016 Brookvale Ln Ste 200
Knoxville, TN 379194092
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- April 21, 2025
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Tennessee #MD20355
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023018728. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
282,534
Distinct HCPCS
10
Medicare allowed
$5,620,574
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 45,800 | 33 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 35,100 | 160 | $23 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 29,580 | 24 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 29,340 | 17 | $47 | |
J0185 |
Injection, aprepitant, 1 mg | 25,870 | 34 | $2 | |
J9271 |
Injection, pembrolizumab, 1 mg | 18,000 | 13 | $54 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 14,910 | 14 | $10 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 12,800 | 94 | $21 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 11,930 | 20 | $42 | |
J1449 |
Injection, eflapegrastim-xnst, 0.1 mg | 6,336 | 15 | $32 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 1,953. This provider delivers 145× the peer median.Open Payments
Industry payments received
All-time total
$3,781
Transactions
136
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 23 | $404.41 | |
| E.R. Squibb & Sons, L.L.C. | 16 | $346.12 | |
| GlaxoSmithKline, LLC. | 8 | $280.16 | |
| Gilead Sciences, Inc. | 8 | $254.17 | |
| AstraZeneca Pharmaceuticals LP | 9 | $252.62 | |
| Merck Sharp & Dohme LLC | 9 | $235.68 | |
| ABBVIE INC. | 13 | $231.94 | |
| Celgene Corporation | 15 | $199.88 | |
| Daiichi Sankyo Inc. | 7 | $166.07 | |
| Genentech USA, Inc. | 8 | $163.35 | |
| Aveo Pharmaceuticals, Inc. | 4 | $120.37 | |
| Janssen Biotech, Inc. | 6 | $105.50 | |
| GENZYME CORPORATION | 4 | $100.66 | |
| McKesson Drug Company LLC | 1 | $99.51 | |
| Novartis Pharmaceuticals Corporation | 5 | $98.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
739
Patients
206
Total drug cost
$2,434,754
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 123 | 47 | $2,198 |
| Prednisone | Generic | 66 | 26 | $489 |
| Hydroxyurea | Generic | 62 | 22 | $2,577 |
| Allopurinol | Generic | 61 | 18 | $395 |
| Ondansetron Hcl | Generic | 49 | 18 | $268 |
| Pomalyst (Pomalidomide) | Brand | 45 | 0 | $775,501 |
| Potassium Chloride | Generic | 45 | 22 | $485 |
| Revlimid (Lenalidomide) | Brand | 42 | 0 | $651,890 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 42 | 12 | $2,467 |
| Dexamethasone | Generic | 39 | 17 | $603 |
Hospital affiliations
Frequently asked questions
What is Dr. Ross Kerns's medical specialty?
Dr. Ross Kerns practices Hematology & Oncology Physician in Knoxville, TN.
Where does Dr. Ross Kerns practice?
Dr. Ross Kerns practices at 9957 Sherrill Blvd, Knoxville, TN 379323366. Office phone: 8656392255.
What is Dr. Ross Kerns's NPI?
Dr. Ross Kerns's National Provider Identifier (NPI) is 1023018728, issued by NPPES.
Does Dr. Ross Kerns accept Medicare assignment?
Yes. Dr. Ross Kerns accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ross Kerns commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, denosumab, 1 mg (HCPCS J0897); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138). Source: CMS Medicare Physician & Other Practitioners file.